{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:13:10Z","timestamp":1697382790100},"reference-count":3,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,7]]},"DOI":"10.1093\/jnci\/dji412","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T21:32:45Z","timestamp":1133904765000},"page":"1791-1792","source":"Crossref","is-referenced-by-count":8,"title":["Re: Cetuximab Therapy and Symptomatic Hypomagnesemia"],"prefix":"10.1093","volume":"97","author":[{"given":"Kadri","family":"Altundag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozden","family":"Altundag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Z.","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selahattin","family":"Turen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa A.","family":"Atik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,7]]},"reference":[{"key":"key\n\t\t\t\t20171013005527_BIB1","doi-asserted-by":"crossref","unstructured":"Schrag D, Chung KY, Flombaum C, Saltz L. Cetuximab therapy and symptomatic hypomagnesemia. \n            J Natl Cancer Inst2005\n            ;\n            97\n            :\n            1221\n            \u20134.","DOI":"10.1093\/jnci\/dji242"},{"key":"key\n\t\t\t\t20171013005527_BIB2","unstructured":"Tarceva package insert. Available at: \n            http:\/\/www.tarceva.com\/tarceva\/professional\/prescribing\/PI.jsp\n            . [Last accessed: August 30, \n            2005\n            .]"},{"key":"key\n\t\t\t\t20171013005527_BIB3","unstructured":"PDR information for Iressa Tablets. Available at: \n            http:\/\/www.drugs.com\/PDR\/Iressa_Tablets.html\n            . [Last accessed: August 30, \n            2005\n            .]"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/97\/23\/1791\/7687040\/dji412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T04:55:47Z","timestamp":1507870547000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/97\/23\/1791\/2521543\/Re-Cetuximab-Therapy-and-Symptomatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,7]]},"references-count":3,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2005,12,7]]},"published-print":{"date-parts":[[2005,12,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dji412","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12,7]]},"published":{"date-parts":[[2005,12,7]]}}}